ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Panel Appointments On President’s Desk; Breast Cancer Treatment Workshop Planned

September 14, 1979

Mammography’s Best Role Is Screening, Kopans Assert

March 18, 1994

In Brief: Morton Leaves UCLA Surgical Oncology; Rall Resigns As NIH Deputy for Intramural Research

May 17, 1991

ACS Adopts ‘Measures of Success’ To Mark Progress T0 Yr. 2000

April 17, 1992

Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases

October 21, 2011

Letters: NCI Mammography Statement Recognizes Patient Autonomy

February 25, 1994